text.skipToContent text.skipToNavigation

Hinweis nur für Kunden in Indonesien  Details anzeigen
Sind Sie ein Kunde aus Indonesien?
Kundensupport
Verbraucherbeschwerdestelle, PT DKSH Indonesia,

(Geschäftseinheit Performance Materials, Sales Support Team)

Adresse

Gebäude AIA Central, Ebene 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesien

+62 21 2988 8557

[email protected]

Generaldirektion für Verbraucherschutz und Handelsordnung, Ministerium für Handel der Republik Indonesien
0853 1111 1010

Erfolg! Ihre Anfrage wurde an unser Vertriebsteam übermittelt.

Etwas ist schiefgelaufen! Bitte versuchen Sie es später erneut.

  • /_ui/responsive/common/custom/images/default-supplier-banner-1.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-2.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-3.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-4.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-5.jpg

ZYDUS CADILA

Zydus Cadila is a leading Indian pharmaceutical company with a global presence. Established in 1952, the company focuses on developing and manufacturing a wide range of healthcare products, including generic drugs, vaccines, and herbal remedies. They prioritize research and development and have received regulatory approvals from major authorities worldwide. Notably, Zydus Cadila has contributed to the fight against COVID-19 with the development of ZyCoV-D, the world's first plasmid DNA-based vaccine. Committed to sustainability and social responsibility, Zydus Cadila operates in over 50 countries, making a significant impact on global healthcare.

 

Mediengalerie

  • Product quantity has been updated.